scholarly article | Q13442814 |
P50 | author | Lucina Bobadilla-Morales | Q54435083 |
Lucina Bobadilla-Morales | Q54435088 | ||
Jorge Román Corona-Rivera | Q55711739 | ||
P2093 | author name string | Alfredo Corona-Rivera | |
Juan S Armendáriz-Borunda | |||
Betsy Annel González-Quezada | |||
Helia Judith Pimentel-Gutiérrez | |||
Rocío Silva-Cruz | |||
César Cenobio Barba-Barba | |||
Citlalli Ortega-De-La-Torre | |||
Fernando Antonio Sánchez-Zubieta | |||
P2860 | cites work | Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis | Q44189582 |
Cytoprotective and Cytotoxic Effects of Curcumin: Dual Action on H2O2-Induced Oxidative Cell Damage in NG108-15 Cells | Q44433662 | ||
Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. | Q52973572 | ||
[Expression of nuclear transcription factor kappaB in childhood acute lymphoblastic leukemia and its significance] | Q80817829 | ||
NF-kappaB in carcinoma therapy and prevention | Q81768343 | ||
Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl | Q28213620 | ||
Nuclear factor-kappaB activation: from bench to bedside | Q28262629 | ||
Apoptosis: a review of programmed cell death | Q28305845 | ||
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. | Q31012437 | ||
Dose escalation of a curcuminoid formulation | Q33236898 | ||
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells | Q33906004 | ||
I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma | Q34133753 | ||
Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage. | Q34466500 | ||
Targeting transcription factors for cancer gene therapy. | Q34494104 | ||
Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin | Q34626926 | ||
Curcumin and cancer: an "old-age" disease with an "age-old" solution | Q34776812 | ||
Phase II trial of curcumin in patients with advanced pancreatic cancer | Q34796370 | ||
Multiple molecular targets in cancer chemoprevention by curcumin | Q36616301 | ||
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia | Q36724661 | ||
Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues | Q36869637 | ||
Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin | Q37089549 | ||
Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Q37163664 | ||
Inflammation and cancer: how friendly is the relationship for cancer patients? | Q37316105 | ||
Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? | Q37378063 | ||
NF-kappaB as a critical link between inflammation and cancer | Q37412699 | ||
8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis | Q37468730 | ||
Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. | Q37676478 | ||
Curcumin, a component of turmeric: from farm to pharmacy | Q38075863 | ||
Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia | Q39425215 | ||
Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells. | Q40267420 | ||
Dosage effects of curcumin on cell death types in a human osteoblast cell line | Q40290259 | ||
Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma | Q40397270 | ||
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. | Q42496035 | ||
Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells | Q43787464 | ||
Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. | Q44049912 | ||
P433 | issue | 5 | |
P921 | main subject | lymphoblastic leukemia | Q18553852 |
curcumin | Q312266 | ||
NF-κB | Q411114 | ||
P304 | page(s) | 4117-4124 | |
P577 | publication date | 2016-09-30 | |
P1433 | published in | Oncology Letters | Q20640514 |
P1476 | title | Curcumin potentiates the effect of chemotherapy against acute lymphoblastic leukemia cells via downregulation of NF-κB. | |
P478 | volume | 12 |
Q49906268 | Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells |
Q91644083 | Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia |
Q92669135 | In vitro effect of curcumin in combination with chemotherapy drugs in Ph+ acute lymphoblastic leukemia cells |
Q47729970 | Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. |
Search more.